| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Wilson Ophthalmic Corp is a Mustang, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accucare Inc is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Regency Hospital Company, LLC is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Regency Hospital Company, LLC is based in Alpharetta, GA. You can find more information on Regency Hospital Company, LLC at www.regencyhospital.com
Established in 1973, the National Health Foundation (NHF) is an innovative leader in seeking ways to improve the healthcare delivery system. One of the Foundation's first initiatives was the development of a bioengineering program for hospitals. This